Presentations

EATG Ageing with HIV Session in Glasgow

Tuesday 30 October, 12.45-13.50 hrs, Clyde Auditorium, Glasgow

Quality of Life Across Different Age Groups of People Living with HIV: A Community Perspective In collaboration with the European AIDS Treatment Group (EATG)

Moderators: Lene Ryom, Copenhagen, Denmark and Alain-Volny Anne, Paris, France

12.45–12.50 Introduction and Project Overview: Koen Block, EATG

12.50–13.00 People living with HIV/AIDS aged 50+: Brian West, EATG and Giovanni Guaraldi, Modena, Italy

13.00–13.10 Children and adolescents (aged 0-25): Sanja Belak Skugor, Zagreb, Croatia and Caroline Foster, London, UK

13.10–13.20 People who have lived with HIV/AIDS at least 10 years (aged 18-50): Jackie Morton, EATG and Ferdinand Wit, Amsterdam, The Netherlands

13.20–13.50 Panel Discussion

Georg Behrens, Hannover, Germany

Nikos Dedes, EATG

General

Comments

Comments

Phase 3 - NEW CHALLENGES AND UNMET NEEDS OF PEOPLE LIVING AND AGEING WITH HIV/AIDS AGED 18 - 50

Quality of Life and Preventive Healthcare , 3-6 May 2018 Alfavito Hotel, Kyiv, Ukraine

DAY 1: Thursday, 3 May 2018

18:00-19:30 Opening Session

Overview of the Ageing with HIV project

Long term health perspectives of people living with HIV in Europe

Challenges and unmet needs - Patient perspective

DAY 2: Friday, 4th May 2018

09:00 - 10:00 The Long-Term Management of HIV and Quality of Life

Patient reported outcomes measures to enhance the person-centredness of care

Beyond Viral Suppression: A European Initiative to Improve HIV Outcomes

10:00 – 11:15 Sexual Health

Sexuality and well-being, sexual dysfunction in women and men

U = U: what does this mean for people living with HIV and for people who cannot obtain an undetectable viral load

11:45 – 12:45 Reproductive Health

4M: Mentor Mothers Living with HIV. 4M Project: My health My choice My child my life.

Fatherhood and HIV

13:45 - 14:45 Psychosocial well-being

Impact of HIV on family and social relationships

Intimate Partner Violence and HIV

15:15 - 16:15 Mental Health and HIV

The experience of living with mental health and HIV

Screening for mental health disorders in people living with HIV, Biomarkers of depression, Treatment fatigue and mental health

16:15 – 17:45 Psychoactive substances and HIV

ART adherence and drug use - CARUSEL experience

Recreational drug use; how to manage drug interactions with HIV/HCV meds

Chemsex

17:45 - 18:00 DAY 2 CONCLUSIONS - Koen Block (EATG, Belgium)

DAY 2 CONCLUSIONS

DAY 3: Saturday, 5th May 2018

09:00 - 11:00 Comorbidities and Preventative Healthcare

HIV and Exercise

Cervical / anal screening

HIV ageing and Tuberculosis: epidemiological situation, treatment programs

Oral Health

Neurocognitive impairment

Prevention and interventions addressing risk factors of NCDs

13:30 - 15:00 Multi-vulnerability populations

Sex workers

Unmet needs of multi-vulnerable migrants: what are the challenges to improve the quality of life and preventive health

Prisoners: HIV and access to care and treatment

The Experiences and Challenges of African Migrant MSM in Accessing HIV prevention screening and treatment services

People who use drugs (PWUD)

Trans people

Juno Roche, (ClinQ/SWIFT/Sophia Forum, UK)

Chronic immune activation and inflammation

Giulia Marchetti (University of Milan, Italy)

17:10 - 17:30 DAY 3 CONCLUSIONS – Koen Block (EATG, Belgium)

DAY 3 CONCLUSIONS

DAY 4: Sunday, 6th May 2018

09:00 –10:15 HIV CURE - managing expectations

Overview

Current status of cure research

HIV patients and health professionals viewpoints and preferences regarding hypothetical participation in Cure trials - The ANRS-APSEC survey

10:45 – 12:15 The role of technology in HIV management

Diagnostics

The EmERGE project - mHealth in HIV

Linkage to treatment and prevention through the use of technology. An introduction to Life4me+

How do people living with HIV want to use technology to manage their health?

12:05 - 12:45 Wrap-up: End of conference

Key outcomes: Research

Key outcomes: Training

Closing & acknowledgements

Phase 2 - Children and adolescents living with HIV/AIDS (aged 0-25)
Conference from 19 to 22 January 2017, Bucharest, Romania

DAY 1: Thursday, 19th January 2017

18:00-19:30 Opening Session

Wellcome

HIV infection among young people in EU/EEA - analysis of 30 years of data reporting

My personal journey

Long Term Medical, Psychological and Social Services for Children Living and Ageing with HIV/AIDS at Baylor Centre of Excellence in Constanta, Romania - Challenges and Lesson Learned

DAY 2: Friday, 20th January 2017

09:00-10:00 Testing in children and adolescents

(National Institute for Infectious Diseases, Romania)

Which tests? The challenges and obstacles in testing infants and young people

(Kabangwe Creative Initiative Association-Zambia working in partnership with Paediatrics AIDS Treatment for Africa, PATA-Cape Town)

The challenges of testing in resource poor settings in high prevalence areas

(UNICEF)
Testing in resource poor settings in high prevalence areas - the challenges and obstacles

10:00-11:15 Disclosure: how and when?

(National Institute for Infectious Diseases, Romania)
Clinical practise in disclosure

(Ukraine)
Personal testimony

(Kindergarten Nestwärme, Germany)
Open and Honest Practises when working with children

(UNICEF / PENTA)
Making it understandable

11:45-13:00 Paediatric ARV formulations

(University of Padova and Penta Foundation, Padova, Italy)
ARV drug optimization for young people in different age groups

14:00-15:15 Pharmacology of ARVs

(Institute of Translational Medicine, University of Liverpool, UK)
Drug-drug interactions and the developing body

(Children’s National Health System, Elizabeth Glaser Pediatric AIDS Foundation,USA)
Pharmacogenetics of antiretroviral therapy in paediatrics

DAY 2 CONCLUSIONS

Koen Block

DAY 3: Saturday, 21st January 2017

09:15 - 11:00 Development and co-morbidities in children and adolescents

(UCL, UK; European Pregnancy and Paediatric HIV Cohort Collaboration; PENTA)
Cognitive function in young people with and without HIV in England

(Equal Opportunities, Tajikistan)
Hepatitis

(University of the Witwatersrand, South Africa)
Physiotherapy

(Imperial College London, UK)
Malignancies in perinatal HIV

(National Institute of Infectious Diseases "Prof. Dr. Matei Bals", Romania)
Cardiac lesions in HIV infected children

11:30 - 13:00 Sexual and reproductive health

(Imperial College London, UK)
Reproductive challenges and trends in long term HIV positive infections (male and female)

(IPPF, Belgium)
Sexual rights and sexuality

14:00 - 15:00 Adherence and doctor–patient relationship

(Imperial College London, UK)
The importance of developing a relationship with your young patient and obtaining and maintaining an undetectable viral load

16:00 -16:30 PEP and PreP

(Children’s National Health System, Elizabeth Glaser Pediatric AIDS Foundation,USA)
Pre and Post Exposure Prophylaxis for HIV in Children and Adolescents

16:30 - 17:00 HIV cure and paediatric research

(Imperial College London CHERUB Research Consortium, UK)
How latent reservoirs are established and maintained in children

17:00 - 17:15 DAY 3 CONCLUSIONS

DAY 3 CONCLUSIONS

DAY 4: Sunday, 22nd January 2017

09:00 –10:00 Mental health (and Physical rehabilitation)

10:00 –11:00 Transition services into adult care

12.45 – 13.00 End of conference

(EATG / Policy Working Group)
Key outcomes: Policy

(EATG / European Community Advisory Board, ECAB)
Key outcomes: Research

(Lux Vitae, Croatia)
Challenges of living with HIV and going through stages of development - impact on mental health

(Sverdlovsk Region Public Foundation of the Social Projects Novoye Vremya, Russia)
Limitations and restrains for providing services for children and adolescents

(MRC Clinical Trials Unit at UCL, UK)
Anxiety and depression in young people with and without perinatal HIV in the AALPHI cohort, England

(UNICEF / PENTA)
Transitioning from childhood to adulthood - where does HIV fit?

(Ukraine)
Peer support

(UCL, UK; European Pregnancy and Paediatric HIV Cohort Collaboration; PENTA)
Children and young people living with perinatal HIV in Europe: numbers and clinical outcomes in adult care